Morphine-induced reduction of intraocular pressure and pupil diameter: Role of nitric oxide
Morphine-induced reduction of intraocular pressure and pupil diameter: Role of nitric oxide
复制标题
DOI:
10.1159/000091993
复制
发表时间:
2006-01-01
期刊:
影响因子:
3.1
通讯作者:
Russell, Karen R. M.
中科院分区:
文献类型:
--
作者:
Dortch-Carnes, Juanita;Russell, Karen R. M.
The present study was performed to evaluate the role of nitric oxide in the intraocular pressure (IOP) lowering effect and in the miotic action of morphine. The IOP was measured in conscious, normal, dark-adapted New Zealand white rabbits using a calibrated pneumatonometer. Experiments were conducted, in which rabbits' eyes were treated with morphine topically and unilaterally, while the fellow eyes received vehicle. IOP and pupil diameter (PD) measurements were taken 0.5 and 0 h before morphine administration and 0.5,11, 2, 3, 4, and 5 h thereafter. The effects of a nonselective opioid receptor antagonist (naloxone), a nitric oxide synthase inhibitor (N omega-nitro-L-arginine methyl ester; L-NAME), and a sulfhydryl reagent (reduced L-glutathione; GSH) on morphine-mediated changes in IOP and PD were also determined. Morphine (10, 33, and 100 mu g) produced concentration-dependent decreases in IOP and reduced PD in both treated and untreated eyes of New Zealand white rabbits. IOP-lowering effect of morphine (100 mu g) and reduction in PD were both significantly inhibited by pretreatment with naloxone (100 mu g), L-NAME (0.5%), or GSH (100 mu g). The results from this study indicate that morphine-induced ocular hypotension and reduction in PC) are opioid-receptor-mediated responses that are associated with the release of nitric oxide. Because the mu 3 opioid receptor subtype has a nitric-oxide-releasing activity and is sensitive to inactivation by GSH, it is concluded that morphine-induced ocular hypotension and miosis are mediated, in part, by activation of mu 3 opioid receptors. Copyright (c) 2006 S. Karger AG, Basel.